Drug Enforcement D-0791-2023

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Status

Ongoing

Classification

Class II

Report Date

June 7, 2023

Termination Date

—

Product Information

Product description
Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains one packaged tray which contains: 1 vial with lyophilized powder for reconstitution, 1 pre-filled syringe with diluent, 1 20-gauge needle, 1 27-gauge needle, Sterile - For subcutaneous use only, Rx Only, Manufactured by: GP Pharm S.A. Barcelona, Spain (ESP) -08777, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031. ALL NDCs
Product quantity
N/A
Reason for recall
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA and Puerto Rico

Location & Firm

Recalling firm
Akorn, Inc.
Address
5605 Centerpoint Ct Ste A, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0791-2023
Event ID
91788
Recall initiation date
April 26, 2023
Center classification date
June 1, 2023
Code info
All Lots
More code info
—